Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
Published Online: 2014-12-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: A Keith Stewart•Ai-Min Hui•Alessandra Di Bacco•Deborah Berg•Eileen Liao•Jacob P Laubach•Jesus G Berdeja•Jonathan L Kaufman•Jose Estevam•Mehdi Hamadani•Neeraj Gupta•Parameswaran Hari•Paul G Richardson•Robert Vescio•Ruben Niesvizky•Sagar Lonial•Shaji K Kumar•Vincent Rajkumar•Vivek Roy
